Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancer Research|March 20, 2019
An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1-HK2+ Multiple MyelomaShili Xu, Tianyuan Zhou, Hanna M Doh, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 8, 2024
Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapyYan-Ruide Li, Yang Zhou, Jiaji Yu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2025
Addition of Ianalumab (VAY736) to Ibrutinib in Patients with Chronic Lymphocytic Leukemia on Ibrutinib Therapy: Results from a Phase Ib StudyKerry A Rogers, Pearlly Yan, Ian W Flinn, et al.Cancer Discovery|November 23, 2022
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin LymphomaSarah M Larson, Christopher M Walthers, Brenda Ji, et al.Cell Reports. Medicine|November 29, 2021
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapyYan-Ruide Li, Yang Zhou, Yu Jeong Kim, et al.Nature Medicine|April 17, 2023
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trialZachary D Crees, Michael P Rettig, Reyka G Jayasinghe, et al.Nature Biotechnology|May 14, 2024
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture methodYan-Ruide Li, Yang Zhou, Jiaji Yu, et al.Cell Stem Cell|September 10, 2019
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for CancerYanni Zhu, Drake J Smith, Yang Zhou, et al.Pageof 2